| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.096 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |